within Pharmacolibrary.Drugs.ATC.S;

model S01AE01_1
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 0.00021666666666666666,
    adminDuration  = 600,
    adminMass      = 200 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.088,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.038,
    k12             = 20,
    k21             = 20
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>S01AE01_1</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Ofloxacin is a broad-spectrum fluoroquinolone antibiotic used for several types of bacterial infections. It is listed in many formularies and approved for human use both systemically and ophthalmically.</p><h4>Pharmacokinetics</h4><p>Reported pharmacokinetic parameters for intravenous administration in healthy adult volunteers.</p><h4>References</h4><ol><li><p>Bethell, DB, et al., &amp; White, NJ (1996). Pharmacokinetics of oral and intravenous ofloxacin in children with multidrug-resistant typhoid fever. <i>Antimicrobial agents and chemotherapy</i> 40(9) 2167–2172. DOI:<a href=\"https://doi.org/10.1128/AAC.40.9.2167\">10.1128/AAC.40.9.2167</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/8878600/\">https://pubmed.ncbi.nlm.nih.gov/8878600</a></p></li><li><p>Brockhaus, L, et al., &amp; Marzolini, C (2019). Revisiting systemic treatment of bacterial endophthalmitis: a review of intravitreal penetration of systemic antibiotics. <i>Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</i> 25(11) 1364–1369. DOI:<a href=\"https://doi.org/10.1016/j.cmi.2019.01.017\">10.1016/j.cmi.2019.01.017</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/30771529/\">https://pubmed.ncbi.nlm.nih.gov/30771529</a></p></li><li><p>Goa, KL, &amp; Noble, S (2003). Panipenem/betamipron. <i>Drugs</i> 63(9) 913–926. DOI:<a href=\"https://doi.org/10.2165/00003495-200363090-00005\">10.2165/00003495-200363090-00005</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/12678575/\">https://pubmed.ncbi.nlm.nih.gov/12678575</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end S01AE01_1;
